Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XH-S003 in Patients With Primary IgA Nephropathy
NCT07634744Phase 2Completed
- Sponsor
- Fosun Pharma
- Start
- Dec 2024
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
A Phase 2 trial of XH-S003 in IgA nephropathy (IgAN), sponsored by Fosun Pharma. Started Dec 2024; status: completed.
02
Drugs
XH-S003
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on NCT07634744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07634744.